Financial Ratios

EPIC ENZYMES PHARMACEUTICALS & INDL. CHEMICALS LTD.

NSE : NABSE : 524374ISIN CODE : INE278A01014Industry : Pesticides & AgrochemicalsHouse : Private
BSE1.710 (0 %)
PREV CLOSE ( ) 1.71
OPEN PRICE ( ) 1.87
BID PRICE (QTY) 1.71 (1)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 501
TODAY'S LOW / HIGH ( )1.71 1.87
52 WK LOW / HIGH ( ) 1.711.87
NSE
This Company is not listed in NSE
Select year
ParticularsMar2012Mar2011Mar2010Mar2009Mar2008
Operational & Financial Ratios
   Earnings Per Share (Rs)-0.27-16.37-1.24-2.49-10.29
   CEPS(Rs)-0.20-16.30-0.76-2.01-9.53
   DPS(Rs)0.000.000.000.000.00
   Book NAV/Share(Rs)-22.86-22.68-7.22-6.06-3.65
   Tax Rate(%)0.000.000.00-0.20-0.09
Margin Ratios
   Core EBITDA Margin(%)-405.70-438.70-78.21-97.35
   EBIT Margin(%)-3775.55-634.65-89.11-87.09
   Pre Tax Margin(%)-5591.61-844.85-102.45-135.34
   PAT Margin (%)-5591.61-844.85-102.66-135.45
   Cash Profit Margin (%)-5567.73-517.76-82.71-125.51
Performance Ratios
   ROA(%)-4.30-103.96-5.21-10.31-34.09
   ROE(%)0.000.000.000.00-726.52
   ROCE(%)-7.67-100.42-4.91-10.28-25.30
   Asset Turnover(x)0.000.020.010.100.25
   Sales/Fixed Asset(x)0.000.020.000.070.23
   Working Capital/Sales(x)0.000.250.091.441.64
Efficiency Ratios
   Fixed Capital/Sales(x)60.26223.5913.574.34
   Receivable days135.42301.01167.91113.28
   Inventory Days1692.105090.91382.01286.73
   Payable days432.971647.43171.3965.11
Valuation Parameters
   PER(x)0.000.000.000.000.00
   PCE(x)-9.81-0.15-4.05-1.02-0.48
   Price/Book(x)-0.08-0.11-0.43-0.34-1.25
   Yield(%)0.000.000.000.000.00
   EV/Net Sales(x)106.08212.6412.374.03
   EV/Core EBITDA(x)-142.8523.45-58.50-16.52-5.22
   EV/EBIT(x)-105.30-2.48-30.83-12.71-4.62
   EV/CE(x)4.554.411.141.221.18
   M Cap / Sales9.5422.790.920.60
Growth Ratio
   Net Sales Growth(%)-100.0090.96-93.91-70.66-24.36
   Core EBITDA Growth(%)-116.74337.6370.4371.56-180.37
   EBIT Growth(%)97.59-1081.8156.8067.27-120.28
   PAT Growth(%)98.37-1214.8150.0875.76-65.46
   EPS Growth(%)98.37-1214.7850.0875.76-65.46
Financial Stability Ratios
   Total Debt/Equity(x)-1.15-1.15-3.58-4.22-7.20
   Current Ratio(x)1.441.561.281.813.01
   Quick Ratio(x)1.041.190.950.761.75
   Interest Cover(x)-429.00-2.08-3.02-6.68-1.81
   Total Debt/Mcap(x)13.6510.538.3412.515.76

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.